ResMed
682 hedge funds and large institutions have $25.3B invested in ResMed in 2021 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 233 increasing their positions, 253 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
682
Holders Change
+25
Holders Change %
+3.81%
% of All Funds
11.98%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.21%
New
80
Increased
233
Reduced
253
Closed
46
Calls
$65.1M
Puts
$59.6M
Net Calls
+$5.45M
Net Calls Change
-$14.4M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$93.7M |
| 2 |
Two Sigma Advisers
New York
|
+$73.6M |
| 3 |
Two Sigma Investments
New York
|
+$64.5M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$45.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.4M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$103M |
| 2 |
JPMorgan Chase & Co
New York
|
-$65.7M |
| 3 |
Morgan Stanley
New York
|
-$58.4M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$57.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$55.3M |
